Loading...
What Else Can CD39 Tell Us?
As the rate-limiting enzyme in ATP/ADP–AMP–adenosine pathway, CD39 would be a novel checkpoint inhibitor target in preventing adenosine-triggered immune-suppressive effect. In addition, CD39(hi) Tregs, but not CD25(hi) Tregs, exhibit sustained Foxp3 levels and functional abilities, indicating it cou...
Na minha lista:
| Udgivet i: | Front Immunol |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Frontiers Media S.A.
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5479880/ https://ncbi.nlm.nih.gov/pubmed/28690614 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2017.00727 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|